Publications

5532 Results

GM-CSF did not allow doxorubicin dose escalation in the maid regimen: A phase I trial. A Southwest Oncology Group study

Authors
LG Hicks;SP Balcerzak;M Zalupski
Journal / Conference
Cancer Investigation 14(6):507-512
Year
1996
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8922

Phase II evaluation of ifosfamide/mesna in metastatic prostate cancer. A Southwest Oncology Group study.

Authors
SK Williamson;MK Wolf;MA Eisenberger;MA O'Rourke;W Brannan;ED Crawford
Journal / Conference
American Journal of Clinical Oncology (CCT) 19(4):368-370
Year
1996
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8719

Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive and estrogen receptor-positive breast cancer patients: A Southwest Oncology Group study.

Authors
SE Rivkin;S Green;J O'Sullivan;AB Cruz;MD Abeloff;WR Jewell;JJ Costanzi;WB Farrar;CK Osborne
Journal / Conference
Journal of Clinical Oncology 14(1):46-51
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Intraperitoneal mitoxantrone or floxuridine: Effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy-A randomized phase II study by the Southwest Oncology Group.

Authors
FM Muggia;PY Liu;DS Alberts;DL Wallace;RV O'Toole;KY Terada;EW Franklin;GW Harrer;DA Goldberg;EV Hannigan
Journal / Conference
Gynecologic Oncology 61:395-402
Year
1996
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8835

Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: An analysis of two intergroup studies.

Authors
KS Albain;SR Green;AS Lichter;LF Hutchins;WC Wood;IC Henderson;JN Ingle;J O'Sullivan;CK Osborne;S Martino
Journal / Conference
Journal of Clinical Oncology 14(11):3009-3017
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-8814, SWOG-8897

Costs of quality-of-life research in Southwest Oncology Group trials

Authors
CM Moinpour
Journal / Conference
Journal of the National Cancer Institute Monographs 20:11-16
Year
1996
Research Committee(s)
Cancer Control

Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the t(8;21) chromosomal translocation in pediatric acute myeloid leukemia.

Authors
L Pearson;CP Leith;MH Duncan;IM Chen;T McConnell;K Trinkaus;K Foucar;CL Willman
Journal / Conference
Leukemia 10:1274-1282
Year
1996
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9007

Correlation of PML-RARa mRNA transcript type with morphology, cytogenetics and clinical parameters in actue promyelocytic leukemia.

Authors
D Viswanatha;KJ Kopecky;K Doss;C Rankin;DR Head;RE Magenis;FR Appelbaum;CL Willman
Journal / Conference
Intl Academy of Pathology Book of Abstracts :125A(#730)
Year
1996
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9007, SWOG-9129 (INT-0129)

Phase 3, randomized, multi-center comparison of zoladex versus surgical ovariectomy in premenopausal patients with receptor positive metastatic breast cancer.

Authors
CW Taylor;S Green;WS Dalton;S Martino;JN Ingle;NJ Robert;CK Osborne
Journal / Conference
Proc Sixth International Congress on Anti-Cancer Treatment :(#120)
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-8692 (INT-0075)

A phase II trial of piroxantrone in endometrial cancer: Southwest Oncology Group study 8918.

Authors
VK Malviya;PY Liu;DA Goldberg;A Hantel;RV O'Toole;RW Roach;ME Conrad;DS Alberts
Journal / Conference
Anti-Cancer Drugs 7(5):527-530
Year
1996
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8918